Chinese Medicinal Herbs Use in Managing Cancer

Chapter

Abstract

For millennia, traditional Chinese medicine (TCM) practitioners have treated cancer with Chinese medicinal herbs (CMHs), which continue to be used in combination with conventional chemotherapy and radiotherapy in contemporary oncologic care in Asia. Recent advances in biochemistry and immunology have allowed discovery of the biologically active components of CMH and the mechanisms of their anti-cancer activities. This chapter provides an overview of CMH use in treating cancer, including discussion of the anti-cancer mechanisms for individual herbs that are commonly used to treat cancer in contemporary TCM practice. Most CMH cancer research studies have involved in vitro and in vivo animal studies, with a relative paucity of well designed, placebo-controlled human clinical trials. Despite this, there is evidence that CMH may mitigate immunosuppression from conventional chemotherapy and radiotherapy, reduce side effects from those treatments, and improve cancer patients’ overall clinical status. Chinese medicinal herbs may produce tumour apoptosis, reduce metastases, and increase survival, either alone or in combination with conventional chemotherapy. Some CMHs interfere with conventional chemotherapy when administered simultaneously, yet enhance conventional chemotherapy efficacy when administered sequentially. Further controlled clinical trials of CMH with/without conventional chemotherapy and radiotherapy in cancer patients are needed to determine which herbs (and herb combinations) to use and the optimal timing of their administration to optimize cancer patients’ survival, reduce tumour burden, enhance immunologic function and improve quality of life while minimizing the side effects (e.g. nausea/vomiting, anorexia and fatigue) of conventional radiotherapy or chemotherapy.

References

  1. Abbate S. Advanced techniques in oriental medicine. Stuttgart: Georg Thieme Verlag; 2006.Google Scholar
  2. About herbs, botanicals, and other products. Memorial Sloan Kettering Cancer Center. http://www.mskcc.org/mskcc/html/69128.cfm.
  3. Asian Anti-Cancer Materia Database. http://asiancancerherb.info/bai%20hua%20she%20she%20cao.htmGoogle Scholar
  4. Bakuridze AD, Kurtsikidze MS, Pisarev VM et al. Immunomodulators of plant origin. Pharm Chem J. 1993;27:589–95.CrossRefGoogle Scholar
  5. Barton DL, Soori GS, Bauer BA et al. Pilot study of Panax quinquefolius (American ginseng) to improve cancer-related fatigue: a randomized, double-blind, dose-finding evaluation: NCCTG trial N03CA. Support Care Cancer. 2009;doi: 10.1007/s00520-009-0642–2Google Scholar
  6. Byeon SE, Lee YG, Cho JY. Regulatory effects of Codonopsis lanceolata on gene expression of GM-CSF in macrophage-like cells. J Ethnopharmacol. 2009;123:185–9.CrossRefPubMedGoogle Scholar
  7. Campbell M. Chinese herb/chemotherapy interactions in breast cancer. California Breast Cancer Research Program Research Portfolio. http://www.cbcrp.org/research/ PageGrant.asp?grant_id=2568
  8. Cao GW, Yang WG, Du P. Observation of the effects of LAK/IL-2 therapy combined with Lycium barbarum polysaccharides in the treatment of 75 cancer patients. Chunghua Chung Liu Tsa Chih. 1994;16:428–31.PubMedGoogle Scholar
  9. Cha YY, Lee EO, Lee HJ et al. Methylene chloride fraction of Scutellaria barbata induces apoptosis in human U937 leukemia cells via the mitochondrial signaling pathway. Clin Chim Acta. 2004;348:41–8.CrossRefPubMedGoogle Scholar
  10. Chan SW. Review of scientific research on edible bird’s nest. http://www.hkfsta.com.hk/articles/special/article7.htm. Accessed 2009
  11. Cho WC, Chen HY. Transcatheter arterial chemoembolization combined with or without Chinese herbal therapy for hepatocellular carcinoma: meta-analysis. Expert Opin Invest Drugs. 2009a;18:617–35.CrossRefGoogle Scholar
  12. Cho WC, Chen HY. Clinical efficacy of traditional Chinese medicine as a concomitant therapy for nasopharyngeal carcinoma: a systematic review and meta-analysis. Cancer Invest. 2009b;27:334–44.CrossRefPubMedGoogle Scholar
  13. Cho WC, Leung KN. In vitro and in vivo immunomodulating and immunorestorative effects of Astragalus membranaceus. J Ethnopharmacol. 2007;113:132–41.CrossRefPubMedGoogle Scholar
  14. Cohen I, Tagliaferri M, Tripathy D. Traditional Chinese medicine in the treatment of breast cancer – part three. http://www.cancerlynx.com/chinesemedicine3.html.
  15. Dawes N. Constitutional treatment ‘fortify the righteous, secure the root’. http://www.pacificcollege.edu/alumni/newsletters/summer2004/30.html.
  16. DeJonge H, Vanrenterghem Y. Aristolochic acid: the common culprit of Chinese herbs nephropathy and Balkan endemic nephropathy. Nephrol Dial Transplant. 2008;23:39–41.CrossRefGoogle Scholar
  17. Duan P, Wang ZM. Clinical study on effect of Astragalus in efficacy enhancing and toxicity reducing of chemotherapy in patients of malignant tumor. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2002;22:515–7.PubMedGoogle Scholar
  18. Duke JA, Ayensu ES. Medicinal plants of China. Algonac: Reference Publications Inc.; 1985.Google Scholar
  19. Gaeddert A. Chinese herbs for immune disorders. http://www.pacificcollege.edu/alumni/newsletters/summer2005/herbs.html.
  20. Gao Y, Tang W, Dai X et al. Effects of water soluble Ganoderma lucidum polysaccharides on the immune function of patients with advanced lung cancer. J Med Food. 2005;8:159–68.CrossRefPubMedGoogle Scholar
  21. Guo R, Canter P, Ernst E. No evidence supporting the use of individualised herbal medicine in any indication. Focus Altern Complement Ther. 2007;12:244–7.Google Scholar
  22. Gupta S, Zhang D, Yi J et al. Anticancer activities of Oldenlandia diffusa. J Herb Pharmacother. 2004;4:21–33.CrossRefPubMedGoogle Scholar
  23. Herbs at a Glance: National Center for Complementary and Alternative Medicine. http://nccam.nih.gov/health/herbsataglance.htm.
  24. Herbst RS, Langer CJ. Epidermal growth factor receptors as a target for cancer treatment: the emerging role of IMC-C225 in the treatment of lung and head and neck cancer. Semin Oncol. 2002;29:27–36.CrossRefPubMedGoogle Scholar
  25. Kong YC, Keung WM, Yip TT et al. Evidence that epidermal growth factor is present in swiftlet’s (collocalia) nest. Comp Biochem Physiol B. 1987;87:221–6.CrossRefPubMedGoogle Scholar
  26. Koo HN, Hong SH, Song BK et al. Taraxacum officinale induces cytotoxicity through TNFα and IL-1α secretion in Hep G2 cells. Life Sci. 2004;74:1149–57.CrossRefPubMedGoogle Scholar
  27. Lahans T. The treatment of colorectal cancer using chemotherapy and Chinese herbal medicine. Chin Med Times. 2008;3:4.Google Scholar
  28. Lee KY, Jeon YJ. Macrophage activation by polysaccharide isolated from Astragalus membranaceus. Int Immunopharmacol. 2005;5:1225–33.CrossRefPubMedGoogle Scholar
  29. Lee J, Lee K, Son Y et al. Stimulating effects on mouse splenocytes of glycoproteins from the herbal medicine Atractylodes macrocephala Koidz. Phytomedicine. 2007;14:390–5.CrossRefPubMedGoogle Scholar
  30. Li W, Lien EJ. Fu-zhen herbs in the treatment of cancer. Orient Heal Arts Int Bull. 1986;11:1–8.Google Scholar
  31. Liang HL, Xue CC, Zhou DH et al. Chinese herbal medicine for lung cancer: a critical literature review (continued). Chin J Integr Med. 2003;9:232–6.Google Scholar
  32. Liu Y, Ye F, Qiu GU et al. Effects of lactone I from Atractylodes macrocephala Koidz on cytokines and proteolysis-inducing factors in cachectic cancer patients. Di Yi Jun Yi Da Xue Bao. 2005;25:1308–11.Google Scholar
  33. Mingji P. Cancer treatment with Fuzheng Peiben principle. Fuzhou: Fujian Science and Technology Press; 1992.Google Scholar
  34. National Cancer Institute Cancer topics. PC-SPES PDQ. http://www.cancer.gov/cancertopics/ pdq/cam/pc-spes/healthprofessional/allpages.
  35. National Cancer Institute Cancer Topics. Selected Vegetables/Sun’s Soup PDQ. http://www.cancer.gov/cancertopics/pdq/cam/vegetables-sun-soup/healthprofessional/allpages.
  36. Ng MH, Chan KH, Kong YC. Potentiation of mitogenic response by extracts of the swiftlet’s (collocalia) nest. Biochem Int. 1986;13:521–31.PubMedGoogle Scholar
  37. Nortier JL, Muniz Martinez MC et al. Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi). NEJM. 2000;342:1686–92.CrossRefPubMedGoogle Scholar
  38. Okamoto Y, Suzuki A, Ueda K et al. Anti-estrogenic activity of prenylated isoflavones from Millettia pachycarpa: Implications for pharmacophores and unique mechanisms. J Health Sci. 2006;52:186–91.CrossRefGoogle Scholar
  39. Pharmacopoeia Commission. Pharmacopoeia of the People’s Republic of China. Beijing: Chemical Industry Press; 2005.Google Scholar
  40. Porter SF, Stuart GA. Chinese medicinal herbs: a modern edition of a classic 16th edition manual. Mineola, NY: Dover Press; 2003.Google Scholar
  41. Rugo H, Shtivelman E, Perez A et al. Phase I trial and antitumor effects of BZL101 for patients with advanced breast cancer. Breast Cancer Res Treat. 2007;105:17–28.CrossRefPubMedGoogle Scholar
  42. Schreck JH. A patient’s guide to Chinese medicine: Dr Shen’s handbook of acupuncture & herbs. Port Richmond, CA: Bay Tree Publishing; 2008.Google Scholar
  43. Shan BE, Zhang JY, Du XN. Immunomodulatory activity and anti-tumor activity of Oldenlandia diffusa in vitro. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2001;21:370–4.PubMedGoogle Scholar
  44. Shin HR, Kim JY, Yun TK et al. The cancer-preventive potential of Panax ginseng: a review of human and experimental evidence. Cancer Causes Control. 2000;11:565–76.CrossRefPubMedGoogle Scholar
  45. Skibola CF, Curry JD, VandeVoort C et al. Brown kelp modulates endocrine hormones in female Sprague-Dawley rats and in human luteinized granulosa cells. J Nutrition. 2005;135:296–300.Google Scholar
  46. Tang XP, Guo FL, Wang ZQ. Clinical oncology guidelines for commonly used Chinese medicine. Scientific and Technical Literature Publishing House; 2006.Google Scholar
  47. Upton R. Astragalus. In: Coates P, Blackman M, Cragg G, et al., editors. Encyclopedia of dietary supplements. New York: Marcel Dekker; 2005. pp. 25–30.Google Scholar
  48. Walter R. Options: the alternative cancer therapy book. New York: Avery Publishing Group; 1993.Google Scholar
  49. Wei X, Chen Z, Yang X et al. Medicinal herbs for esophageal cancer. Cochrane Database Syst Rev. 2007;2:CD004520.PubMedGoogle Scholar
  50. Wong BY, Nguyen DL, Lin T et al. Chinese medicinal herb Scutellaria barbata modulates apoptosis and cell survival in murine and human prostate cancer cells and tumor development in TRAMP mice. Eur J Cancer Prev. 2009;18:331–41.CrossRefPubMedGoogle Scholar
  51. Woo JH, Li D, Wilsbach K et al. Coix seed extract, a commonly used treatment for cancer in China, inhibits NFkappaB and protein kinase C signaling. Cancer Biol Ther. 2007;6:2005–11.CrossRefPubMedGoogle Scholar
  52. Wu T, Munro AJ, Guanjian L et al. Chinese medical herbs for chemotherapy side effects in colorectal cancer patients. Cochrane Database Syst Rev. 2005;1:CD004540.Google Scholar
  53. Yu F, Gao J, Zeng Y et al. Inhibition of Coix seed extract on fatty acid synthase, a novel target for anticancer activity. J Ethnopharmacol. 2008;119:252–8.CrossRefPubMedGoogle Scholar
  54. Yu SJ, Tseng J. Fu-Ling, a Chinese herbal drug, modulates cytokine secretion by human peripheral blood monocytes. Int J Immunopharmacol. 1996;18:37–44.CrossRefPubMedGoogle Scholar
  55. Zhang RX, Li MX, Jia ZP. Rehmannia glutinosa: review of botany, chemistry and pharmacology. J Ethnopharmacol. 2008;117:199–214.CrossRefPubMedGoogle Scholar
  56. Zhang M, Liu X, Li J et al. Chinese medicinal herbs to treat the side-effects of chemotherapy in breast cancer patients. Cochrane Database Syst Rev. 2007;2:CD004921.PubMedGoogle Scholar
  57. Zhu M. translator. The medical classic of the yellow emperor. Beijing: Foreign Languages Press; 2001.Google Scholar
  58. Zneg XL, Li XA, Zhang BY. Immunological and hematopoietic effect of Codonopsis pilosula on cancer patients during radiotherapy. Zhongguo Zhong Xi Yi Jie He Za Zhi. 1992;12:607–8.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2010

Authors and Affiliations

  1. 1.Mayo ClinicRochesterUSA

Personalised recommendations